These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.

AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...

(IN BRIEF) AstraZeneca presented significant advancements ... diff) infections, which can cause severe intestinal issues. In addition, vaccine effectiveness data on FluMist, the only self-administered ...

In September, AstraZeneca's subsidiary MedImmune gained approval for a live H1N1 Flumist vaccine. Further afield, Beijing-based Sinovac Biotech also received approval for an H1N1 vaccine from the ...

If you’re on the fence about investing in AstraZeneca PLC, Merck & Co. or Inc. because you ... Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, ...

But next year, you could get vaccinated for the flu at home. Just last month, the FDA approved FluMist, a nasal-spray flu ...

Now that the U.S. Food and Drug Administration has approved the at-home use of the flu vaccine spray FluMist, how do you know that it's the right choice for you and your family? One expert offers ...